Unknown

Dataset Information

0

"Hard" Drug Repurposing for Precision Oncology: The Missing Link?

ABSTRACT:

SUBMITTER: Pantziarka P 

PROVIDER: S-EPMC6010551 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

"Hard" Drug Repurposing for Precision Oncology: The Missing Link?

Pantziarka Pan P   Bouche Gauthier G   André Nicolas N  

Frontiers in pharmacology 20180614

Similar Datasets

Unknown Oncology Drug Repurposing for Sepsis Treatment.
| S-EPMC9030585 | biostudies-literature
Unknown Pan‐cancer analysis and oncogenic implications of MGAM and MGAM2: Toward precision oncology and drug repurposing in colorectal cancer
| S-EPMC12381534 | biostudies-literature
Unknown Comparative oncology approach to drug repurposing in osteosarcoma.
| S-EPMC5868798 | biostudies-literature
Unknown Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology.
| S-EPMC10837507 | biostudies-literature
Unknown Challenges and opportunities for oncology drug repurposing informed by synthetic lethality.
| S-EPMC12738840 | biostudies-literature
Unknown The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
| S-EPMC7014347 | biostudies-literature
Unknown Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health.
| S-EPMC6294046 | biostudies-literature
Unknown Independent Drug Action in Combination Therapy: Implications for Precision Oncology.
| S-EPMC8904281 | biostudies-literature
Unknown PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing.
| S-EPMC10303868 | biostudies-literature
Unknown Breast cancer PDxO cultures for drug discovery and functional precision oncology.
| S-EPMC10339058 | biostudies-literature